Bacterial fermentation
Ophthalmology
Pe-Ha-Luron® F
Pe-Ha-Luron® F is a high-quality viscoelastic substance based on bio-fermented sodium hyaluronate for intraocular application. As an essential excipient for ophthalmological procedures, the product ensures that the anterior chamber remains stable during the procedure and the surrounding tissue is protected. To ensure that the correct concentration is available for each individual surgical technique, we offer Pe-Ha-Luron® F in six different concentrations.
- No cooling required
- Preserves the anterior eye chamber and the capsular sac
- Supports a controlled capsulorhexis
- Excellent protection of the endothelial cells
- Easy to inject
- Better adhesion to the endothelium during phacoemulsification
- Excellent protection against mechanical forces
- Sterile
- CE-certified
Pe-Ha-Blue® PLUS
Pe-Ha-Blue® PLUS is a very innovative product in the ALBOMED® portfolio. It was developed to make ophthalmic surgeries quicker, simpler, safer and more efficient. Pe-Ha-Blue® PLUS combines the outstanding viscoelastic properties of Pe-Ha-Luron® F with trypan blue. In addition to the common functions of viscoelastic solutions, this combination also increases the contrast for the surgeon, which leads to more safety during the procedure. Pe-Ha-Blue® PLUS is provided as a sterile product in a ready-to-use syringe.
- No cooling required
- Preserves the anterior eye chamber and the capsular sac
- Supports a controlled capsulorhexis
- Excellent protection of the endothelial cells
- Easy to inject
- Better adhesion to the endothelium during phacoemulsification
- Excellent protection against mechanical forces
- Sterile
- CE-certified
Publications & Articles
- Blaue Periode – die neue Stilphase der Ophthalmochirurgie – Ophthalmologische Nachrichten 05/2019 (Download pdf →)
- "Blue period" - the new stylistic phase of ophthalmic surgeons? (Download pdf →)
-
Evaluation of a Novel Blue-Colored Ophthalmic Viscoelastic Device Applied during
Phacoemulsification in Eyes with Pseudoexfoliation Syndrome;
Case Rep Ophthalmol 2019; 10: 101-109 - Pe-Ha-Blue® Symposium results ESCRS 2018 (Download pdf →)